scholarly article | Q13442814 |
P50 | author | Amit Golding | Q56250347 |
Molly Hritzo | Q93004970 | ||
P2093 | author name string | Luca Tamagnone | |
Achsah D Keegan | |||
Svetlana P Chapoval | |||
Xiulan Qi | |||
P2860 | cites work | Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor | Q21263141 |
Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity | Q24302386 | ||
Neuroimmune semaphorin 4A downregulates the severity of allergic response | Q24601341 | ||
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
p53-Dependent and p53-independent activation of autophagy by ARF | Q28264892 | ||
Neuroimmune semaphorin 4D is necessary for optimal lung allergic inflammation | Q28295886 | ||
Sema4A induces cell morphological changes through B-type plexin-mediated signaling | Q28506174 | ||
Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice | Q28585413 | ||
Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs. | Q30371156 | ||
Tim-2 regulates T helper type 2 responses and autoimmunity | Q33220331 | ||
Allergic diseases and asthma: a global public health concern and a call to action | Q33712275 | ||
Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. | Q34154039 | ||
Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies | Q34197736 | ||
Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG. | Q34274920 | ||
Neuroimmune semaphorin 4A as a drug and drug target for asthma | Q34367862 | ||
The role of the transcription factor Foxp3 in the development of regulatory T cells | Q34569892 | ||
Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells | Q34617154 | ||
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. | Q34655006 | ||
A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells | Q34696683 | ||
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer | Q34729938 | ||
CD4 T cells: fates, functions, and faults | Q34813153 | ||
Differences in Expression Level of Helios and Neuropilin-1 Do Not Distinguish Thymus-Derived from Extrathymically-Induced CD4+Foxp3+ Regulatory T Cells | Q35818676 | ||
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. | Q36299565 | ||
The costimulatory role of TIM molecules | Q37474954 | ||
The antiproliferative effect of kefir cell-free fraction on HuT-102 malignant T lymphocytes | Q37602865 | ||
Suppression assays with human T regulatory cells: a technical guide. | Q37967572 | ||
Asthma phenotypes: the evolution from clinical to molecular approaches | Q38007831 | ||
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. | Q38662974 | ||
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia | Q38810781 | ||
Semaphorins 4A and 4D in chronic inflammatory diseases. | Q38935490 | ||
Regulatory T cells in allergic diseases. | Q38946820 | ||
A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma. | Q38956459 | ||
Prospects for new and emerging therapeutics in severe asthma: the role of biologics | Q39278773 | ||
Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions | Q39331928 | ||
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. | Q39402881 | ||
Innate and adaptive type 2 immunity in lung allergic inflammation. | Q39402938 | ||
Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance | Q39744464 | ||
Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes. | Q40195952 | ||
Neuropilin-1: a surface marker of regulatory T cells | Q40584286 | ||
Regulation of CD3 expression in a protein kinase C isozyme-deficient T-cell line | Q41509951 | ||
Cytokines in chronic respiratory diseases | Q42113962 | ||
ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways | Q42365296 | ||
An inhibitory role for Sema4A in antigen-specific allergic asthma | Q45211082 | ||
Antigen presentation by the CD4 positive monocyte subset | Q45214423 | ||
TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors | Q45877917 | ||
IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells | Q46040716 | ||
Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells | Q47240613 | ||
Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion | Q47561020 | ||
Imaging flow cytometry: A method for examining dynamic native FOXO1 localization in human lymphocytes | Q47654601 | ||
Omalizumab effectively protects against early and late allergic responses in asthma after 4 weeks. | Q48329241 | ||
Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4. | Q50325168 | ||
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells. | Q53268361 | ||
Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. | Q54597061 | ||
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells | Q56903036 | ||
CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility | Q56914602 | ||
A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response | Q57218726 | ||
T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas | Q71529097 | ||
Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells | Q73401157 | ||
CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen | Q73520530 | ||
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer | Q79920604 | ||
T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation | Q80283980 | ||
Biologicals for asthma in patients with asthma-COPD overlap | Q89425137 | ||
P433 | issue | 2 | |
P304 | page(s) | 71-87 | |
P577 | publication date | 2019-02-01 | |
P1476 | title | Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1 | |
P478 | volume | 3 |
Search more.